| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5679897 | Journal of the Formosan Medical Association | 2017 | 8 Pages |
Abstract
In Asian patients with AF, NOACs, regardless of dosing regimens, have a similar feature of preserved efficacy with improved safety compared with warfarin.
Keywords
Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial FibrillationApixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial FibrillationARISTOTLERandomized Evaluation of Long-Term Anticoagulation TherapyAsian patientsRE-LYNon-vitamin K antagonist oral anticoagulantsAtrial fibrillationSportif
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Kang-Ling Wang, Chun-Chih Chiu, Doreen Su-Yin Tan, Chun-Yi Lin, En-Yu Lai, Shinya Goto, Robert P. Giugliano, Chern-En Chiang,